primary mediastinal B cell lymphoma

Research in Review

New Therapy May Effectively Treat Rare B-Cell Malignancy

05/18/2017

JCP Editors

A new treatment for a rare B-cell malignancy provided an objective response rate of 41% in a clinical trial, published in Blood (published online May 10, 2017; doi:10.1182/blood-2016-12-758383). ----- Related...

A new...

05/18/2017

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

primary mediastinal B cell lymphoma

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products